Singapore Stocks: Eu Yang Sang, Genting, Indofood Agri, Stats

Singapore’s Straits Times Index gained 0.4 percent to 3,142.62 at the close. The gauge fell 1 percent this week, trimming the month’s advance to 1.5 percent. Two stocks rose for each that declined on the 30-member gauge.

Shares on the measure trade at an average 15.3 times estimated earnings, compared with about 17.4 times at the beginning of the year, according to data compiled by Bloomberg.

The following shares were among the most active in the market. Stock symbols are in parentheses after the company name.

Eu Yan Sang International Ltd. (EYSAN SP), a retailer of traditional Chinese medicine, advanced 1.7 percent to 91 Singapore cents. The company said first-quarter profit increased 14 percent to S$4.1 million ($3.2 million).

Genting Singapore Plc (GENS SP), owner of one of two casino resorts in the city-state, gained 0.5 percent to S$2.17. RHB Capital Bhd raised its share-price forecast to S$2.55 from S$2.40 and maintained its “outperform” rating.

Indofood Agri Resources Ltd. (IFAR SP), the palm-oil unit of Indonesia’s biggest noodle maker, fell 1.9 percent to S$2.60. The company said third-quarter net income fell 8.7 percent from a year earlier to 360 billion rupiah ($40.3 million).

Jardine Cycle & Carriage Ltd. (JCNC SP), the automotive distributor that gets 89 percent of sales from Indonesia, rose 0.4 percent to S$39.30. Its unit PT Astra International (ASII IJ), Indonesia’s biggest automotive retailer, posted a 37 percent jump in third-quarter net income to 3.92 trillion rupiah.

Stats Chippac Ltd. (STAT SP), the chip-testing and packaging company controlled by Temasek Holdings Pte, declined 3.6 percent to 95 Singapore cents. The company said third- quarter profit fell to $24.2 million from $25.1 million a year earlier even as revenue increased 10.9 percent.

To contact the reporter on this story: Jonathan Burgos in Singapore at jburgos4@bloomberg.net.

To contact the editor responsible for this story: Darren Boey at dboey@bloomberg.net.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.